E 117
Pill imprint E 117 has been identified as Labetalol hydrochloride 200 mg.
Labetalol is used in the treatment of high blood pressure; hypertensive emergency; pheochromocytoma; mitral valve prolapse and belongs to the drug class non-cardioselective beta blockers. Risk cannot be ruled out during pregnancy.
Labetalol 200 mg is not subject to the Controlled Substances Act.
See also related documents.
Labetalol hydrochloride Images
- Imprint:
-
E 117
- Strength:
- 200 mg
- Color:
- White
- Size:
- 10.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- corn starch
hypromelloses
lactose monohydrate
magnesium stearate
polyethylene glycol
polysorbate 80
sodium starch glycolate type A potato
titanium dioxide
- Drug Class:
- Non-cardioselective beta blockers
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Sandoz Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00185-0117
| NDC Code | Manufacturer / Repackager |
|---|---|
| 51079-0929 | UDL Laboratories Inc |
| 63739-0366 | McKesson Packaging Services |
Note: Inactive ingredients may vary.
Advertisement
More Labetalol Hydrochloride resources
- Labetalol (Wolters Kluwer)
- Labetalol Tablets (Wolters Kluwer)
- labetalol (Cerner Multum)
- labetalol (Micromedex) - Includes Dosage Information
- labetalol Intravenous (Micromedex) - Includes Dosage Information
- Labetalol Hydrochloride (AHFS DI)
- Labetalol (FDA)
- Labetalol Tablets (FDA)
- Trandate Injection (FDA)
- Labetalol Hydrochloride (Wolters Kluwer)
Search Again
